Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-05-30 Sale |
2023-06-01 7:25 pm |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
131,245 | $38.9 | $5,104,970 | 81,682 (Direct) |
View |
2023-05-24 Sale |
2023-05-26 7:10 pm |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
31,655 | $41.41 | $1,310,931 | 45,602 (Indirect Direct) |
View |
2023-03-24 Sale |
2023-03-24 7:18 pm |
Xenon Pharmaceuticals Inc. | XENE | KENNEY CHRISTOPHER JOHN Chief Medical Officer |
700 | $35.01 | $24,507 | 0 (Direct) |
View |
2023-03-07 Sale |
2023-03-09 6:21 pm |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
19,232 | $36.98 | $711,199 | 55,006 (Direct) |
View |
2022-11-23 Sale |
2022-11-28 8:41 pm |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
3,994 | $34.55 | $138,000 | 36,073 (Indirect Direct) |
View |
2022-09-02 Sale |
2022-09-07 4:26 pm |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
15,355 | $39.57 | $607,597 | 0 (Direct) |
View |
2022-08-31 Sale |
2022-09-02 4:27 pm |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
65,231 | $38.31 | $2,499,023 | 16,796 (Direct) |
View |
2022-08-12 Sale |
2022-08-16 5:36 pm |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
57,743 | $38.31 | $2,211,978 | 10,000 (Direct) |
View |
2022-08-12 Sale |
2022-08-16 5:31 pm |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
177,135 | $38.25 | $6,775,149 | 6,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-06-02 Option Award |
2023-06-02 5:29 pm |
N/A 2033-06-01 |
Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director |
18,475 | $0 | 18,475 (Direct) |
View |
2023-06-02 Option Award |
2023-06-02 5:27 pm |
N/A 2033-06-01 |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
18,475 | $0 | 18,475 (Direct) |
View |
2023-06-02 Option Award |
2023-06-02 5:25 pm |
N/A 2033-06-01 |
Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director |
18,475 | $0 | 18,475 (Direct) |
View |
2023-06-02 Option Award |
2023-06-02 5:24 pm |
N/A 2033-06-01 |
Xenon Pharmaceuticals Inc. | XENE | Svoronos Dawn Director |
18,475 | $0 | 18,475 (Direct) |
View |
2023-06-02 Option Award |
2023-06-02 5:22 pm |
N/A 2033-06-01 |
Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director |
18,475 | $0 | 18,475 (Direct) |
View |
2023-06-02 Option Award |
2023-06-02 5:21 pm |
N/A 2033-06-01 |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
18,475 | $0 | 18,475 (Direct) |
View |
2023-06-02 Option Award |
2023-06-02 5:20 pm |
N/A 2033-06-01 |
Xenon Pharmaceuticals Inc. | XENE | Machado Patrick Director |
18,475 | $0 | 18,475 (Direct) |
View |
2023-06-01 Tax Withholding |
2023-06-01 7:25 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
22,605 | $38.53 | 81,682 (Direct) |
View |
2023-05-31 Exercise |
2023-06-01 7:25 pm |
N/A 2024-01-13 |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
134,153 | $0 | 81,682 (Direct) |
View |
2023-05-31 Exercise |
2023-06-01 7:25 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
29,835 | $9.85 | 81,682 (Direct) |
View |
2023-06-01 Exercise |
2023-06-01 7:25 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
9,318 | $7.69 | 81,682 (Direct) |
View |
2023-05-31 Exercise |
2023-06-01 7:25 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
95,000 | $17.76 | 81,682 (Direct) |
View |
2023-05-31 Tax Withholding |
2023-06-01 7:25 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
29,309 | $38.37 | 81,682 (Direct) |
View |
2023-05-24 Exercise |
2023-05-26 7:10 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
42,592 | $9.44 | 45,602 (Direct) |
View |
2023-05-24 Tax Withholding |
2023-05-26 7:10 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
12,383 | $41.84 | 45,602 (Direct) |
View |
2023-05-24 Exercise |
2023-05-26 7:10 pm |
N/A 2023-07-31 |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
69,340 | $0 | 45,602 (Direct) |
View |
2023-05-24 Exercise |
2023-05-26 7:10 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
26,748 | $9.85 | 45,602 (Direct) |
View |
2023-03-10 Option Award |
2023-03-14 4:47 pm |
N/A 2033-03-09 |
Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer |
90,000 | $0 | 90,000 (Direct) |
View |
2023-03-10 Option Award |
2023-03-14 4:46 pm |
N/A 2033-03-09 |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
75,000 | $0 | 75,000 (Direct) |
View |
2023-03-10 Option Award |
2023-03-14 4:44 pm |
N/A 2033-03-09 |
Xenon Pharmaceuticals Inc. | XENE | DiFabio Andrea Chief Legal Officer |
45,000 | $0 | 45,000 (Direct) |
View |
2023-03-10 Option Award |
2023-03-14 4:36 pm |
N/A 2033-03-09 |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
380,000 | $0 | 380,000 (Direct) |
View |
2023-03-10 Option Award |
2023-03-14 4:32 pm |
N/A 2033-03-09 |
Xenon Pharmaceuticals Inc. | XENE | KENNEY CHRISTOPHER JOHN Chief Medical Officer |
120,000 | $0 | 120,000 (Direct) |
View |
2023-03-10 Option Award |
2023-03-14 4:27 pm |
N/A 2033-03-09 |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
75,000 | $0 | 75,000 (Direct) |
View |
2023-03-10 Option Award |
2023-03-14 4:25 pm |
N/A 2033-03-09 |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
120,000 | $0 | 120,000 (Direct) |
View |
2023-03-07 Exercise |
2023-03-09 6:21 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
30,864 | $2.59 | 55,006 (Direct) |
View |
2023-03-07 Exercise |
2023-03-09 6:21 pm |
N/A 2023-03-10 |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
72,016 | $0 | 55,006 (Direct) |
View |
2023-03-07 Tax Withholding |
2023-03-09 6:21 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
3,778 | $37.13 | 55,006 (Direct) |
View |
2023-03-07 Exercise |
2023-03-09 6:21 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
41,152 | $2.68 | 55,006 (Direct) |
View |
2022-12-12 Exercise |
2022-12-13 4:29 pm |
N/A 2022-12-31 |
Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director |
3,086 | $0 | 69,905 (Direct) |
View |
2022-12-12 Exercise |
2022-12-13 4:29 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director |
3,086 | $2.68 | 69,905 (Direct) |
View |
2022-11-25 Exercise |
2022-11-28 8:41 pm |
N/A 2022-12-31 |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
2,057 | $0 | 36,073 (Direct) |
View |
2022-11-25 Tax Withholding |
2022-11-28 8:41 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
120 | $34.37 | 36,073 (Direct) |
View |
2022-11-25 Exercise |
2022-11-28 8:41 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
2,057 | $2.68 | 36,073 (Direct) |
View |
2022-11-07 Option Award |
2022-11-09 5:04 pm |
N/A 2032-11-06 |
Xenon Pharmaceuticals Inc. | XENE | DiFabio Andrea Chief Legal Officer |
135,000 | $0 | 135,000 (Direct) |
View |
Ownership |
2022-11-09 4:59 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | DiFabio Andrea Chief Legal Officer |
0 | $0 | 0 (Direct) |
View |
2022-09-02 Exercise |
2022-09-07 4:26 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
32 | $7.49 | 0 (Direct) |
View |
2022-09-02 Exercise |
2022-09-07 4:26 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
9,000 | $9.44 | 0 (Direct) |
View |
2022-09-02 Exercise |
2022-09-07 4:26 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
813 | $8.4 | 0 (Direct) |
View |
2022-09-02 Exercise |
2022-09-07 4:26 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
6,511 | $4.75 | 0 (Direct) |
View |
2022-09-02 Exercise |
2022-09-07 4:26 pm |
N/A 2029-09-15 |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
18,648 | $0 | 0 (Direct) |
View |
2022-09-02 Exercise |
2022-09-07 4:26 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
2,292 | $3.1 | 0 (Direct) |
View |
2022-09-02 Tax Withholding |
2022-09-07 4:26 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
3,293 | $39.53 | 0 (Direct) |
View |
2022-08-31 Exercise |
2022-09-02 4:27 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
17,488 | $2.67 | 16,796 (Direct) |
View |
2022-08-31 Tax Withholding |
2022-09-02 4:27 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
1,572 | $37.86 | 16,796 (Direct) |
View |
2022-08-31 Exercise |
2022-09-02 4:27 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
55,000 | $4.75 | 16,796 (Direct) |
View |
2022-08-31 Exercise |
2022-09-02 4:27 pm |
N/A 2022-12-31 |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
72,488 | $0 | 16,796 (Direct) |
View |
2022-09-01 Tax Withholding |
2022-09-02 4:27 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
6,121 | $38.81 | 16,796 (Direct) |
View |
2022-08-12 Exercise |
2022-08-16 5:36 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
45,000 | $4.75 | 10,000 (Direct) |
View |
2022-08-12 Exercise |
2022-08-16 5:36 pm |
N/A 2027-10-22 |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
65,000 | $0 | 10,000 (Direct) |
View |
2022-08-12 Tax Withholding |
2022-08-16 5:36 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
7,257 | $38.02 | 10,000 (Direct) |
View |
2022-08-12 Exercise |
2022-08-16 5:36 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
20,000 | $3.1 | 10,000 (Direct) |
View |
2022-06-28 Option Award |
2022-06-29 5:48 pm |
N/A 2032-06-27 |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Director |
18,000 | $0 | 18,000 (Direct) |
View |
2022-06-28 Option Award |
2022-06-29 5:44 pm |
N/A 2032-06-27 |
Xenon Pharmaceuticals Inc. | XENE | Svoronos Dawn Director |
18,000 | $0 | 18,000 (Direct) |
View |
2022-06-28 Option Award |
2022-06-29 5:40 pm |
N/A 2032-06-27 |
Xenon Pharmaceuticals Inc. | XENE | PATOU GARY Director |
18,000 | $0 | 18,000 (Direct) |
View |
2022-06-28 Option Award |
2022-06-29 5:34 pm |
N/A 2032-06-27 |
Xenon Pharmaceuticals Inc. | XENE | Machado Patrick Director |
18,000 | $0 | 18,000 (Direct) |
View |
2022-06-28 Option Award |
2022-06-29 5:31 pm |
N/A 2032-06-27 |
Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director |
18,000 | $0 | 18,000 (Direct) |
View |
2022-06-28 Option Award |
2022-06-29 5:26 pm |
N/A 2032-06-27 |
Xenon Pharmaceuticals Inc. | XENE | GANNON STEVEN Director |
18,000 | $0 | 18,000 (Direct) |
View |
2022-06-28 Option Award |
2022-06-29 5:23 pm |
N/A 2032-06-27 |
Xenon Pharmaceuticals Inc. | XENE | AZAB MOHAMMAD Director |
18,000 | $0 | 18,000 (Direct) |
View |
2022-03-10 Option Award |
2022-03-14 4:24 pm |
N/A 2032-03-09 |
Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
2022-03-10 Option Award |
2022-03-14 4:21 pm |
N/A 2032-03-09 |
Xenon Pharmaceuticals Inc. | XENE | ROBIN SHERRINGTON EVP, Strategy & Innovation |
75,000 | $0 | 75,000 (Direct) |
View |
2022-03-10 Option Award |
2022-03-14 4:20 pm |
N/A 2032-03-09 |
Xenon Pharmaceuticals Inc. | XENE | PIMSTONE SIMON N. Executive Chair |
25,000 | $0 | 25,000 (Direct) |
View |
2022-03-10 Option Award |
2022-03-14 4:15 pm |
N/A 2032-03-09 |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
400,000 | $0 | 400,000 (Direct) |
View |
2022-03-10 Option Award |
2022-03-14 4:13 pm |
N/A 2032-03-09 |
Xenon Pharmaceuticals Inc. | XENE | KENNEY CHRISTOPHER JOHN Chief Medical Officer |
125,000 | $0 | 125,000 (Direct) |
View |
2022-03-10 Option Award |
2022-03-14 4:11 pm |
N/A 2032-03-09 |
Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer |
125,000 | $0 | 125,000 (Direct) |
View |
2022-03-10 Option Award |
2022-03-14 4:10 pm |
N/A 2032-03-09 |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
65,000 | $0 | 65,000 (Direct) |
View |